We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

158 hedge funds and large institutions have $830M invested in Aerie Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 46 increasing their positions, 61 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 19

38% more capital invested

Capital invested by funds: $601M → $830M (+$229M)

5% more funds holding

Funds holding: 150 → 158 (+8)

25% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 61

25% less call options, than puts

Call options by funds: $3.8M | Put options by funds: $5.06M

Holders
158
Holders Change
+8
Holders Change %
+5.33%
% of All Funds
2.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
46
Reduced
61
Closed
19
Calls
$3.8M
Puts
$5.06M
Net Calls
-$1.26M
Net Calls Change
-$2.71M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$37.3M
2
GIM
Granahan Investment Management
Massachusetts
+$14.3M
3
Principal Financial Group
Principal Financial Group
Iowa
+$9.14M
4
RCMNY
Rubric Capital Management (New York)
New York
+$8.3M
5
ACM
Atika Capital Management
New York
+$8.29M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$11.5M
2
VOYA Investment Management
VOYA Investment Management
Georgia
-$7.87M
3
First Manhattan
First Manhattan
New York
-$6.14M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$5.91M
5
Bank of America
Bank of America
North Carolina
-$5.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCMNY
26
Rubric Capital Management (New York)
New York
$8.59M +$8.3M +480,402 New
ACM
27
Atika Capital Management
New York
$8.58M +$8.29M +480,000 New
Northern Trust
28
Northern Trust
Illinois
$8.09M -$483K -27,935 -6%
FCM
29
Frontier Capital Management
Massachusetts
$7.73M -$594K -34,392 -7%
CS
30
Candriam SCA
Luxembourg
$7.48M – – –
NAM
31
Nexpoint Asset Management
Texas
$7.09M -$791K -45,802 -10%
N
32
Nuveen
North Carolina
$6.47M -$774K -44,788 -11%
IHAM
33
Integral Health Asset Management
New York
$6.25M +$2.59M +150,000 +75%
GIP
34
Granite Investment Partners
California
$6.06M -$2.33M -134,913 -28%
Charles Schwab
35
Charles Schwab
California
$5.34M +$241K +13,945 +5%
DCM
36
DAFNA Capital Management
California
$4.93M -$218K -12,600 -4%
Norges Bank
37
Norges Bank
Norway
$4.38M +$4.32K +250 +0.1%
AGA
38
Altrinsic Global Advisors
Connecticut
$4.29M – – –
Two Sigma Investments
39
Two Sigma Investments
New York
$4.16M +$4.02M +233,029 New
Renaissance Technologies
40
Renaissance Technologies
New York
$4.07M -$1.02M -59,000 -21%
Goldman Sachs
41
Goldman Sachs
New York
$3.92M -$653K -37,808 -15%
VOYA Investment Management
42
VOYA Investment Management
Georgia
$3.89M -$7.87M -455,530 -68%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$3.82M -$57.2K -3,314 -2%
Jacobs Levy Equity Management
44
Jacobs Levy Equity Management
New Jersey
$3.58M -$5.91M -341,947 -63%
Macquarie Group
45
Macquarie Group
Australia
$3.45M +$3.24M +187,381 +3,295%
Fidelity Investments
46
Fidelity Investments
Massachusetts
$3.33M -$459K -26,563 -12%
Allianz Asset Management
47
Allianz Asset Management
Germany
$2.73M – – –
HA
48
Homestead Advisers
Virginia
$2.71M +$553K +32,000 +27%
Voloridge Investment Management
49
Voloridge Investment Management
Florida
$2.53M -$228K -13,210 -9%
EWM
50
Endurance Wealth Management
Rhode Island
$2.28M +$486K +28,160 +28%
1
2
3 4 5

AERI Hedge Fund Activity: Q1 2021 in Review

158 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q1 2021, worth a combined $830M — up 38% from $601M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new AERI positions and 19 closed out — a net gain of 9 holders — while 46 added to existing stakes and 61 trimmed.

The largest buyer was Woodline Partners, opening a new position worth an estimated $37.3M. The largest seller was Deerfield Management, cutting an estimated $11.5M.

  • 158 institutional investors held Aerie Pharmaceuticals (AERI) as of Q1 2021, up from 150 in Q4 2020.
  • Funds reported $830M of Aerie Pharmaceuticals stock for Q1 2021, up 38% quarter-over-quarter.
  • 28 funds opened new Aerie Pharmaceuticals positions in Q1 2021 and 19 closed out, a net change of +9 holders.
  • The largest Aerie Pharmaceuticals buyer in Q1 2021 was Woodline Partners, an estimated $37.3M added.
  • The largest Aerie Pharmaceuticals seller in Q1 2021 was Deerfield Management, an estimated $11.5M sold.

Based on aggregated 13F filings for Q1 2021.